Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

Dateien zu dieser Ressource
Datum
2021Autor
Veeroju, Swathi
Kojonazarov, Baktybek
Weiss, Astrid
Ghofrani, Hossein Ardeschir
Weißmann, Norbert
Grimminger, Friedrich
Seeger, Werner
Novoyatleva, Tatyana
Schermuly, Ralph Theo
Zitierlink
http://dx.doi.org/10.22029/jlupub-6614Erstpublikation in
International journal of molecular sciences 22, 3 (2021), 1-15, 1502